Yazen Health, a healthcare platform based in Sweden focused on obesity treatment, has announced the close of a €19.5 million Series A funding round. This investment will enable Yazen to expand into additional markets and further develop its treatment platform, which integrates weight loss medications with lifestyle guidance from a multidisciplinary team.
The funding round was co-led by Evli Growth Partners from Finland and Helsana HealthInvest from Switzerland, with support from Almaz Capital and Yabeo in Germany, and Swedish investors Luminar Ventures and Aggregate Media.
Tackling the global obesity crisis
Founded in 2021, Yazen has designed a model that combines advanced weight loss medication with a support team that includes doctors, coaches, dietitians, psychologists, and physiotherapists. Yazen has seen promising results in Sweden, serving over 20,000 patients and achieving a 70% retention rate after one year.
Already profitable in Sweden, Yazen plans to use the new funding to strengthen its presence in Spain, Norway, and the Netherlands, while also developing pilot programs in the UK and Germany. Over the next few years, Yazen aims to continue growing and developing its model for broader international use.
Part of the investment will go toward improving Yazen’s app and its patient care model, giving users access to a range of specialists and support. Patients receive assistance with weight loss medication as well as lifestyle adjustments, benefiting from a collaborative approach among Yazen’s healthcare providers.
A new chairman of the board
Yazen welcomes Mikael Hed, founding partner at Evli Growth Partners and former CEO of Rovio (creators of Angry Birds), as the new Chairman of the Board. His background in building and scaling an international brand will be an invaluable asset to Yazen as it enters its next phase of growth.
“We are extremely proud of what we’ve achieved so far and the strong growth we’ve seen in Sweden. This funding gives us the opportunity to continue our mission to defeat obesity on a global scale. With Mikael Hed as our new Chairman and the support of our new investors, we are better positioned than ever to make a difference,” said Fredrik Meurling, CEO and Founder of Yazen.
“Yazen’s comprehensive offering has quickly demonstrated an impressive track record. I look forward to leading the board’s work and, together with both existing and new investors, continuing Yazen’s international expansion,” said Mikael Hed, Growth Partner at Evli Growth Partners.
Read the orginal article: https://www.eu-startups.com/2024/11/stockholm-based-yazen-health-secures-e19-5-million-to-combate-obesity/
